Overview


The Pharmaceutical Logistics Market involves the efficient transportation, storage, and distribution of medicines, vaccines, and healthcare products while ensuring safety, temperature control, and regulatory compliance. With the rise in global healthcare demand, e-commerce pharmacies, and cold-chain innovations, this market focuses on timely delivery, waste reduction, and the maintenance of product integrity from manufacturers to end users.

According to FutureWise analysis, the pharmaceutical logistics market in 2026 is US$104.53 billion, and is expected to reach US$248.16 billion by 2036 at a CAGR of 9.03%. The pharmaceutical distribution sector is undergoing notable technological advancements, characterized by the growing adoption of IoT sensors, the use of blockchain to enhance supply chain transparency, and AI-driven route optimization. These innovations play a crucial role in meeting the stringent requirements of pharmaceutical logistics, especially for high-value specialty drugs and vaccines that require precise control over environmental conditions.

Growth Drivers:

  • Rising global demand for medicines and vaccines.
  • Expansion of e-pharmacies and online healthcare services.
  • Increasing need for temperature-controlled cold chain logistics.
  • Strict regulatory compliance and safety standards.
  • Technological advancements in tracking and supply chain management.

Key Trends:

  • Adoption of cold chain and temperature-controlled logistics for biologics and vaccines.
  • Integration of digital supply chain technologies like IoT, AI, and blockchain.
  • Growth of last-mile delivery services for e-pharmacies and home healthcare.
  • Focus on sustainable, green logistics to reduce the carbon footprint.
  • Increased outsourcing of logistics operations to third-party providers for efficiency.

Market Segmentation and Key Players:

The Pharmaceutical Logistics Market is typically segmented by type (Cold Chain vs. Non-Cold Chain), components (Storage like warehouses and refrigerated containers; Transportation via sea, air, and overland; and Monitoring hardware/software), applications (BioPharma, Chemical Pharma, Specialty Pharma), and regions (North America, Europe, Asia-Pacific, Rest of World). This structure reflects how services are tailored to different product needs, delivery modes, and global demand patterns. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Pharmaceutical Logistics Market include Deutsche Post DHL and FedEx, both known for their extensive cold-chain capabilities and global distribution networks.

Research Methodology:

The research methodology for the Pharmaceutical Logistics Market by FutureWise Research utilizes both secondary and primary data collection. It begins with desktop research from industry reports and databases, followed by expert interviews and surveys with key stakeholders. Market size estimation relies on historical data and forecast models, validated through data triangulation. The study includes segment analysis, regional breakdowns, and competitive mapping for a credible forecast of the global pharmaceutical logistics landscape.

  • Agility
  • Air Canada
  • CEVA Logistics
  • DB Schenker
  • Deutsche Post AG
  • FedEx
  • LifeConEx
  • Marken
  • United Parcel Service of America, Inc.
  • VersaCold Logistics Services
  • Kerry Logistics
  • Biotec Services International (PCI Group)
  • Continental Air Cargo
  • Nordic Logistics and Warehousing, LLC
  • TNT Express
  • Sofrigam SA
  • Kuehne + Nagel

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Pharmaceutical Logistics Market:

United Parcel Service of America, Inc.

  • In Q1 2025, UPS announced its plan to acquire Germany’s Frigo-Trans and Biotech & Pharma Logistics, which will expand its European cold chain warehousing and freight forwarding network.
  • In April 2025, UPS finalized an agreement to acquire Canada’s Andlauer Healthcare Group for approximately USD 1.6 billion, gaining nine distribution centers and twenty-two branches, thereby enhancing its North American healthcare logistics capacity.
  • By combining the previous acquisition of Bomi Group and others, UPS aims to rapidly scale its healthcare logistics business, reaching USD 20 billion by 2026.

Air Canada

  • Plans are in progress to upgrade the cold-chain facility at Toronto Pearson International Airport. The upgrade will feature over 30,000 square feet of temperature-controlled space specifically designed for pharmaceutical shipments. This facility will include strict temperature zones ranging from +2 °C to +8 °C and +15 °C to +25 °C. Additionally, it will incorporate energy-efficient monitoring systems, rapid roll-up doors, and increased unit load capacity.

CEVA Logistics

  • Acquired Borusan Tedarik supply chain, adding approximately 570,000 m² of warehouse space in Turkey, which doubles the capacity for pharmaceuticals and general goods.
  • Presented “CEVA FORPLANET,” a sustainable logistics suite, and emphasized ultra-low temperature blood plasma transport (–35?°C) from India at LogiPharma 2025.

Deutsche Post AG

  • Launched a 32,000 m² Life Sciences Hub in Florstadt near Frankfurt, featuring multiple climate-controlled zones, GMP/GDP certifications, solar-powered sustainable operations, and comprehensive pharmaceutical logistics capabilities.
  • As part of a broader strategy, the company aims for 50% revenue growth by 2030, focusing on specialized pharmaceutical logistics and digital transformation..

By Type

  • Non-cold Chain Logistics
  • Cold Chain Logistics

By Component

  • Storage
    • Warehouse
    • Refrigerated Container
  • Transportation
    • Sea Freight Logistics
    • Air freight logistics
    • Overland Logistics
  • Monitoring Components
    • Hardware
      • Sensors
      • RFID devices
      • Telematics
      • Networking devices
    • Software

By Application

  • BioPharma
  • Chemical Pharma
  • Speciality Pharma

By Region

  • North America
  • Europe
  • Asia-Pacific
  • The rest of the world

Here’s a regional view of where the most progress is happening

North America

  • In 2024, North America held the largest share of the pharmaceutical logistics market, accounting for approximately 34.9% of the global market. This dominant position can be attributed to several factors, including advanced healthcare infrastructure, significant investment levels, a strong presence of major pharmaceutical and logistics companies, and increased government initiatives aimed at promoting pharmaceutical logistics.

Europe 

  • Europe accounted for a substantial revenue share of over 36.81% in 2024 and is projected to experience significant growth through 2033. This high market share is primarily driven by robust growth in pharmaceutical product trading across key European countries, along with well-established regulatory frameworks.

• Tier 1 players-established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Pharmaceutical Logistics Market By Type, By Component, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate competitive landscape mapping-product launches, technological advan Terumoents, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Pharmaceutical Logistics Market Variables, Trends and Scope

    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Pharmaceutical Logistics Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Logistics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Pharmaceutical Logistics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Pharmaceutical Logistics Market, By Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Non-cold Chain Logistics
        2. Cold Chain Logistics

  • 8.   Global Pharmaceutical Logistics Market, By Component Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Storage
         1.1. Warehouse
         1.2. Refrigerated Container
        2. Transportation
         2.1. Sea Freight Logistics
         2.2. Air freight logistics
         2.3. Overland Logistics
        3. Monitoring Components
         3.1. Hardware
          3.1.1. Sensors
          3.1.2. RFID devices
          3.1.3. Telematics
          3.1.4. Networking devices
         3.2. Software

  • 9.   Global Pharmaceutical Logistics Market, By Application Historical Analysis and Forecast 2026-2036 USD Million)

    •   1. Bio Pharma
        2. Chemical Pharma
        3. Speciality Pharma

  • 10.   North America Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape

    • 1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)

    •         1. Agility
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Air Canada
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CEVA Logistics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DB Schenker
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Deutsche Post AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. FedEx
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. LifeConEx
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Marken
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. United Parcel Service of America, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. VersaCold Logistics Services
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Kerry Logistics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        12. Biotec Services International (PCI Group)
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Continental Air Cargo
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Nordic Logistics and Warehousing, LLC
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. TNT Express
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Sofrigam SA
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Kuehne + Nagel
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    • 1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client

    •   

FAQ


The Pharmaceutical Logistics Market emphasizes the storage, handling, and transportation of pharmaceutical products, including drugs, vaccines, medical devices, and biologics, while ensuring strict temperature control, security, and compliance with regulations throughout the supply chain.

Cold Chain Logistics: For products that are sensitive to temperature, such as vaccines, biologics, and insulin.
Non-Cold Chain Logistics: For general medications and healthcare supplies that do not need refrigeration.
 
  • The high operational costs associated with maintaining cold chain systems.
  • The international regulations and customs procedures are complex and can be challenging to navigate.
  • There is a risk of temperature variations leading to product spoilage.
  • There is a shortage of skilled personnel in cold chain management.
     

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

Related Market

Biopharmaceutical Logistics Market

Read More

Healthcare Logistics Market

Read More

Vaccine Transport and Logistics Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11